Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro: Implications for the development of heart failure

Circulation Research

Volumn 79, Issue 3, 1996, Pages 381-387

  Xie, Yi Wu ^a   Shen, Weiqun ^a   Zhao, Gong ^a   Xu, Xiaobin ^a   Wolin, Michael S ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

bradykinin; cardiac dysfunction; cGMP; microvascular endothelium; oxygen consumption

Indexed keywords

2,4 DINITROPHENOL; 8 BROMO CYCLIC GMP; BRADYKININ; BRADYKININ RECEPTOR; CARBACHOL; MUSCARINIC RECEPTOR; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ELECTRON TRANSPORT; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE MUSCLE; HEART RATE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0029816509     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.3.381     Document Type: Article

References (48)

1. Randall WC. Anatomy of blood circulation. In: Abramson DI, Dobrin PB, eds. Blood Vessels and Lymphatics in Organ Systems. Orlando, Fla: Academic Press Inc; 1984:319-326.
2. Rose CP, Goresky CA. Interactions between capillary exchange, cellular entry, and metabolic sequestration processes in the heart. In: Handbook of Physiology, Cardiovascular System, Microcirculation. Bethesda, Md: American Physiological Society; 1984:781-798.
3. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci. 1992;17:399-402.
4. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation. 1992;86:38-46.
5. Wang J, Seyedi N, Xu XB, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol. 1994;266:H670-H680.
6. Shah AM, Fort S, Siney L, Smith JA, Lewis MJ. Endothelium-derived relaxing factor modulates the duration of myocardial contraction. Circulation. 1991;84(suppl II):II-308. Abstract.
7. Granger DL, Lehninger AL. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol. 1982;95:527-535.
8. Drapier JC, Hibbs JB. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells: inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest. 1986;78:790-797.
9. Marletta MA, Yoon PS, Iyengar RD, Leaf C, Wishnok JS. Macrophage oxidation of L-arginine to nitrate and nitrite: nitric oxide is an intermediate. Biochem. 1988;27:8706-8711.
10. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157:87-94.
11. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 1994;75:1086-1095.
12. 2 uptake after inhibition of EDRF/NO synthesis. J Appl Physiol. 1994;76:1166-1171.
13. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
14. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
15. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of 5-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
16. Umbreit WW, Burris RH, Stauffer JF. The solubility of oxygen. In: Manometric Techniques. 4th ed. Minneapolis, Minn: Burgess Pub Co; 1964:5-6.
17. Vanhoulte PM. Endothelium and control of vascular function. Hypertension. 1989;13:658-667.
18. Moncada S. The L-arginine:nitric oxide pathway. Acta Physiol Scand. 1992;145:201-227.
19. Armstrong PW, Stopps TP, Ford SE, deBold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation. 1986;74:1075-1084.
20. Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek N. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation. 1987;75:857-867.
21. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
22. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature. 1992;358:676-678.
23. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
24. Balligand J-L, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91:2314-2319.
25. Balligand J-L, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (Type III) nitric oxide synthase in cardiac myocytes. J Biol Chem. 1995;270:14582-14586.
26. Belhassen L, Kelly RA, Smith TW, Balligand J-L. Nitric oxide synthase (NOS 3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. J Clin Invest. 1996;97:1908-1915.
27. Lohmann SM, Fischmeister R, Walter U. Signal transduction by cGMP in heart. Basic Res Cardiol. 1991;86:503-514.
28. Weiss HR, Rodriguez E, Tse J, Scholz PM. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phospodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin Exp Pharmacol Physiol. 1994;21:607-614.
29. 4 -induced cardiac hypertrophy. Am J Physiol. 1995;268:H686-H691.
30. 2 consumption in rat. Brain Res. 1995;669:35-40.
31. Erecinska M, Wilson DF. Inhibitors of cytochrome c oxidase. Pharmacol Ther. 1980;8:1-20.
32. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AHV. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases. FEBS Lett. 1994;345:50-54.
33. Schweizer M, Richter C. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun. 1994;204:169-175.
34. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994;356:295-298.
35. Lancaster JR, Hibbs JB. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A. 1990;87:1223-1227.
36. Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys. 1994; 308:89-95.
37. Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitase, but nitric oxide does not. J Biol Chem. 1994;269:29405-29408.
38. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu X, Kobari Y, Pritchard K Jr, Sessa WC, Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 1996;78:58-64.
39. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, Sutton MG, Selwyn AP, Alexander RW, Ganz P. Endothelium-dependent dilation of coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990;81:772-779.
40. Hintze TH, Shen W, Seyedi N, Zhao G. Potential roles for changes in coronary and myocyte nitric oxide production in the development of heart failure. Heart failure. 1994;10:116-125.
41. O'Murchu B, Miller VM, Perrella MA, Burnett JC. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest. 1994;93:165-171.
42. Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze TH, Anversa P. The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular hypertrophy. Circulation. 1995;92:2306-2317.
43. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
44. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol. 1991;260:C910-C916.
45. Geng Y, Hansson GK, Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res. 1992;71:1268-1276.
46. Srefanovic-Racic M, Stedler J, Georgescu HI, Evans CH. Nitric oxide and energy production in articular chondrocytes. J Cell Physiol. 1994;159:274-280.
47. Shen W, Hintze TH, Wolin MS. Nitric oxide: an important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation. 1995;92:3505-3512.
48. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor J. J Clin Invest. 1995;95:677-685.